Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 7A1 (COX7A1) is a structural subunit of cytochrome c oxidase (complex IV), which is the terminal enzyme of the mitochondrial electron transport chain responsible for catalyzing the reduction of oxygen to water and driving oxidative phosphorylation[2][3]. The COX7A1 gene encodes a nuclear-encoded, muscle-specific isoform of subunit VIIa, predominantly expressed in heart and skeletal muscle[2][3]. COX7A1 contributes to assembly, structural stability, and regulation of cytochrome c oxidase activity[2]. It plays a role in energy metabolism, cellular respiration, and can impact cell proliferation and death processes such as autophagy and ferroptosis, especially in pathological conditions such as cancer where altered expression has been linked to tumor progression and therapy sensitivity[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 7A1 (COX7A1).